RxDoctor Payments Data

Stephanie Hunstad, MD

Family Medicine · Cincinnati, OHNPI 1295994044

Payments from drug & device makers

$3,854in general payments, 2019–2025

Across 215 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$755
  • Abbott$576
  • Novo Nordisk$421
  • Lilly USA, LLC$250
  • GSK$218
  • Boehringer Ingelheim$193
  • plus $1K from 31 others

What the payments were for

  • Food & beverage$3,854100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,854 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$46,039
Medicare patients
124
Services billed
583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban70$67,388
JardianceEmpagliflozin48$55,888
TrulicityDulaglutide41$54,008
MounjaroTirzepatide19$31,915
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$19,726
FarxigaDapagliflozin Propanediol24$19,482
XareltoRivaroxaban56$17,022
JanuviaSitagliptin Phosphate17$15,226
OzempicSemaglutide12$13,148
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$7,140
Atorvastatin Calcium344$3,027
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$2,372
Gabapentin118$2,117
Levothyroxine Sodium196$1,870
Tretinoin12$1,783

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$250$85,92360 claims
PfizerEliquis$181$67,38870 claims
Boehringer IngelheimJardiance$193$55,88848 claims
GSKTrelegy Ellipta, Anoro Ellipta$218$26,86636 claims
AstraZenecaFarxiga$75$19,48224 claims
Johnson & JohnsonXarelto$31$17,02256 claims
MerckJanuvia$90$15,22617 claims
Novo NordiskOzempic$421$13,14812 claims
AbbVieSynthroid$755$1,25026 claims
Almatica Pharma LLCSertraline Hcl$28$60881 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →